Blood vessel inhibitor shows promise against metastatic thyroid cancer

User rating: 5 / 5 after 3 vote(s)

Thyroid cancer that has spread to distant sites has a poor prognosis, but an experimental drug that inhibits tumor blood vessel formation can slow disease progression in some patients, a research team led by investigators from The University of Texas M. D. Anderson Cancer Center reports in the July 3rd edition of The New England Journal of Medicine.


Full story »
All News summaries from Medicine & Health news
All News summaries for July 03, 2008

Just a numbers game? Making sense of health statistics

Oct 10, 2008 | User rating: not rated yet
Presidential candidates use them to persuade voters, drug companies use them to sell their products, and the media spin them in all kinds of ways, but nobody - candidates, reporters, let alone health consumers - understands ...

Statins may prevent miscarriages

Oct 10, 2008 | User rating: not rated yet
Hospital for Special Surgery researchers have found that statins may be able to prevent miscarriages in women who are suffering from pregnancy complications caused by antiphospholipid syndrome (APS), according to a study ...

A link between mitochondria and tumor formation in stem cells

Oct 10, 2008 | User rating: not rated yet
Researchers report on a previously unknown relationship between stem cell potency and the metabolic rate of their mitochondria –a cell's energy makers. Stem cells with more active mitochondria also have a greater capacity ...

Researcher eliminates viral vector in stem cell reprogramming

Oct 10, 2008 | User rating: not rated yet
Shinya Yamanaka MD, PhD, of Kyoto University and the Gladstone Institute of Cardiovascular Disease (GICD) has taken another step forward in improving the possibilities for the practical application of induced pluripotent ...

On the trail of a targeted therapy for blood cancers

Oct 10, 2008 | User rating: not rated yet
Investigators from the Herman B Wells Center for Pediatric Research at the Indiana University School of Medicine are focusing on a family of blood proteins that they hope holds a key to decreasing the toxic ...
Goto Archive PhysOrg Forum Goto Archive Video Goto Archive Editorials Goto Archive Free Magazines Goto Archive Newsletter

News Archive